Original Research

ESHAP chemotherapy is efficient in refractory/relapsed primary central nervous system lymphoma: report of four cases

Ungur R, Tempescul A, Berthou C, Bagacean C, Radeanu D, Muresan A, Zdrenghea M

OncoTargets and Therapy 2015, 8:2771-2773

Published Date: 1 October 2015